<SEC-DOCUMENT>0001213900-25-015409.txt : 20250219
<SEC-HEADER>0001213900-25-015409.hdr.sgml : 20250219
<ACCEPTANCE-DATETIME>20250219212009
ACCESSION NUMBER:		0001213900-25-015409
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250214
FILED AS OF DATE:		20250219
DATE AS OF CHANGE:		20250219

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Bellevue Global Life Science Investors LLC
		CENTRAL INDEX KEY:			0001953768
		ORGANIZATION NAME:           	
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41390
		FILM NUMBER:		25642967

	BUSINESS ADDRESS:	
		STREET 1:		10900 NE 4TH STREET, SUITE 2300
		CITY:			BELLEVUE
		STATE:			WA
		ZIP:			98004
		BUSINESS PHONE:		(425) 635-7700

	MAIL ADDRESS:	
		STREET 1:		10900 NE 4TH STREET, SUITE 2300
		CITY:			BELLEVUE
		STATE:			WA
		ZIP:			98004

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OSR Holdings, Inc.
		CENTRAL INDEX KEY:			0001840425
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				845052822
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		10900 NE 4TH STREET, SUITE 2300
		CITY:			BELLEVUE
		STATE:			WA
		ZIP:			98004
		BUSINESS PHONE:		425-635-7700

	MAIL ADDRESS:	
		STREET 1:		10900 NE 4TH STREET, SUITE 2300
		CITY:			BELLEVUE
		STATE:			WA
		ZIP:			98004

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bellevue Life Sciences Acquisition Corp.
		DATE OF NAME CHANGE:	20210113
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2025-02-14</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001840425</issuerCik>
        <issuerName>OSR Holdings, Inc.</issuerName>
        <issuerTradingSymbol>OSRH</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001953768</rptOwnerCik>
            <rptOwnerName>Bellevue Global Life Science Investors LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>10900 NE 4TH STREET, SUITE 2300</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>BELLEVUE</rptOwnerCity>
            <rptOwnerState>WA</rptOwnerState>
            <rptOwnerZipCode>98004</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2025-02-14</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>J</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>43000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2043500</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Represents 430,000 private placement rights which were converted into 43,000 shares of common stock at the closing of a business combination between Bellevue Life Science Acquisition Corp. and OSR Holdings Co., Ltd.</footnote>
        <footnote id="F2">Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC, the sponsor of the Issuer (the &quot;Sponsor&quot;) whose general partner is Bellevue Capital Management LLC (&quot;Bellevue Capital&quot;). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>By: Bellevue Capital Management LLC, Its Manager /s/ Kuk Hyoun Hwang, Managing Member</signatureName>
        <signatureDate>2025-02-19</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
